1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Executive Overview and Synthetic Genes Market Introduction
The synthetic genes market has emerged as a cornerstone of modern biotechnology, driving breakthroughs across agriculture, pharmaceuticals, and research domains. As the demand for tailored genetic constructs expands, organizations are investing heavily in cutting‐edge services that accelerate discovery and innovation. This executive summary offers a concise yet comprehensive overview of market dynamics, highlighting pivotal technological advances and regulatory influences shaping the landscape. Readers will gain clarity on the forces propelling growth, the challenges posed by shifting trade policies, and the strategic considerations that industry leaders must address to maintain competitive advantage. By distilling complex developments into actionable insights, this introduction sets the stage for an in-depth exploration of transformative shifts, tariff impacts, segmentation nuances, regional variances, and the profiles of key players driving the sector forward.Transformative Technological and Regulatory Shifts
The landscape of synthetic gene services has undergone profound transformation, driven by exponential improvements in gene editing precision and throughput. Technologies that once required months to deliver constructs now complete workflows in a fraction of the time, enabling rapid iteration and streamlined development pipelines. Simultaneously, the integration of AI-driven design platforms has refined sequence optimization, yielding constructs with enhanced functionality and minimized off-target effects. These technological leaps have democratized access to complex applications, from agricultural strain engineering to advanced therapeutic development.Regulatory frameworks have evolved in parallel, adapting to novel capabilities while balancing safety and ethical considerations. Agencies have introduced accelerated review pathways for CRISPR-based products, incentivizing early adoption by startups and established firms alike. Moreover, collaborative consortia have formed to standardize best practices for gene assembly and synthesis quality control, fostering greater interoperability among service providers.
Together, these shifts have redefined competitive benchmarks, elevating service speed, accuracy, and reliability as the foremost differentiators. Organizations that align their portfolios with these emerging standards are poised to lead in an environment where technological agility dictates market leadership.
Cumulative Impact of U.S. Tariffs in 2025
In 2025, revised United States tariff schedules imposed elevated duties on DNA synthesis reagents and enzyme kits critical to custom gene services. This policy adjustment has reverberated across supply chains, triggering cost increases that have been largely absorbed by providers to preserve customer retention. Companies have renegotiated supplier contracts and diversified procurement strategies to mitigate the financial burden while maintaining service delivery timelines.The tariff-driven expense has also accelerated the adoption of domestic manufacturing for key reagents, as U.S.-based suppliers seek to capture market share by offering tariff-neutral alternatives. This reshoring trend has improved lead times for certain reagent categories, though it has yet to fully offset the price increases on imported specialty enzymes. As a result, end-users have become more selective in ordering custom constructs, prioritizing high-value projects where precision and speed justify premium pricing.
Despite the headwinds, service providers have introduced modular pricing models that decouple basic synthesis from advanced editing and design tiers. By redesigning service bundles around core competencies, firms have preserved margin structures and sustained incremental innovation investments. Looking ahead, continued collaboration between industry associations and policymakers will be critical to refining tariff exemptions for essential R&D materials and preserving the sector’s growth trajectory.
Key Segmentation Insights Across Service and Technology Dimensions
A granular view of market segmentation reveals distinct value propositions across gene type, application, end-user, workflow, technology, product form, and service type. From the perspective of gene type, demand for advanced synthetic genes-such as those leveraging CRISPR gene editing or gene assembly and synthesis-has outpaced interest in basic offerings like custom cloning or site-directed mutagenesis. In application segments, pharmaceutical initiatives in drug and vaccine development coexist alongside agricultural pursuits in genetically modified organisms and plant biotechnology, while research and development efforts in genomics, metabolomics, and proteomics continue to expand.End-user adoption patterns further underscore market complexity. Academic and research institutes, encompassing private research organizations and public universities, exhibit strong demand for standardized gene synthesis. In contrast, biotechnology and pharmaceutical companies-ranging from agile biotech startups to established pharmas-prioritize full gene construct services, often bundled with design, optimization, or replacement offerings. Contract research organizations, both large-scale and small-scale, occupy a strategic niche by outsourcing high-volume synthesis tasks to specialized providers.
Workflow considerations highlight divergence between cloning and subcloning processes, which include fusion and TA cloning methods, and gene synthesis workflows, which span gene fragment synthesis and oligonucleotide synthesis. On the technology front, next-generation sequencing approaches-targeted and whole genome-are complemented by PCR-based platforms such as RT-PCR and traditional PCR.
Product form choices influence procurement, with circular and linear gene fragments competing alongside custom and standard plasmid formats. Finally, service type segmentation shows a clear bifurcation between full gene construct services-entailing gene design, optimization, and replacement-and standard gene synthesis services, which prioritize economical or express turnarounds. Understanding these nuanced segments empowers stakeholders to tailor offerings and capture the most lucrative niches.
Key Regional Market and Investment Dynamics
Regional dynamics underscore differentiated growth drivers and investment priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific territories. In the Americas, robust venture capital flows into biotech startups and a mature pharmaceutical sector have fueled demand for both standard gene synthesis and advanced editing services. Academic collaborations in Latin America have triggered interest in low-cost custom cloning, while North American firms lead in CRISPR-based therapeutic research.The Europe Middle East & Africa region displays a mosaic of regulatory environments and funding mechanisms. Western European nations maintain strong R&D incentives for vaccine and drug development, driving adoption of next-generation sequencing and full gene construct services. Meanwhile, emerging markets in the Middle East have prioritized agricultural biotechnology to enhance food security, leveraging plant biotechnology and genetically modified organism applications. Africa’s academic institutions are increasingly affiliating with international consortia to access high-throughput oligonucleotide synthesis.
In Asia-Pacific, government-sponsored genomics initiatives and large-scale population studies have propelled investments in whole genome sequencing and gene fragment synthesis technologies. Contract research organizations across India and China are expanding capacity for economical gene synthesis, while Japan and South Korea focus on advanced synthesis methods and express turnaround services to support burgeoning precision medicine programs.
Profiles of Leading Synthetic Gene Service Providers
A cadre of leading companies has emerged as pivotal architects of innovation within the synthetic genes ecosystem. Amgen Inc. continues to leverage its deep expertise in protein therapeutics by integrating gene assembly capabilities into downstream development. Bioneer Corporation has distinguished itself with proprietary high-throughput CRISPR screening platforms, complementing its custom cloning services. Eurofins Genomics Europe demonstrates a broad service portfolio that spans whole genome sequencing, targeted sequencing, and plasmid production, supported by an extensive quality management framework.Genewiz, Inc. (Brooks Automation) has scaled its express gene synthesis offerings to deliver ultra-rapid turnarounds, while Genomatica, Inc. focuses on sustainable bio-based product generation using engineered pathways. Genscript Biotech Corporation excels in fusion cloning and mutation analysis, providing end-to-end solutions from gene design through protein expression. Integrated DNA Technologies, Inc. (IDT) maintains leadership in oligonucleotide synthesis, particularly within RT-PCR and traditional PCR workflows.
Sigma-Aldrich Co. LLC (Merck KGaA) capitalizes on its reagent portfolio to supply large-scale CROs and pharmaceutical R&D teams, whereas Thermo Fisher Scientific, Inc. integrates automation and informatics for seamless gene synthesis pipelines. Twist Bioscience Corporation distinguishes itself through silicon-based DNA synthesis, enabling scalable production of gene fragments and plasmids with high fidelity. Each of these organizations has tailored its value proposition to specific service type segments, reinforcing the collaborative yet competitive nature of the market.
Actionable Recommendations for Industry Leaders
Industry leaders must act decisively to secure competitive positioning and foster sustainable growth. First, they should invest in modular service architectures that allow rapid customization of gene constructs without compromising on throughput. This approach ensures flexibility across project scales while preserving margin integrity.Second, forging strategic partnerships with domestic reagent manufacturers can mitigate the risk of international tariff exposure and strengthen supply chain resilience. By establishing joint development agreements, firms can co-innovate novel enzyme formulations that optimize synthesis fidelity and turnaround times.
Third, expanding data analytics capabilities will enable predictive maintenance of synthesis platforms and real-time quality control. Implementing machine learning algorithms to analyze sequence assembly metrics can minimize error rates and reduce rework, translating directly into cost savings and enhanced customer satisfaction.
Fourth, companies should prioritize end-user engagement by developing educational programs and collaborative research initiatives with academic and pharmaceutical partners. This focus not only drives demand for advanced services but also cultivates long-term relationships that yield recurring revenue streams.
Finally, continuous regulatory monitoring and proactive advocacy will ensure that tariff policies and biosecurity guidelines evolve in harmony with technological advances, preserving unfettered access to critical reagents and protecting the integrity of the R&D ecosystem.
Conclusion: Navigating Growth and Innovation
In summary, the synthetic genes services market stands at the nexus of technological innovation, regulatory evolution, and strategic competition. Rapid advancements in gene editing and synthesis technology have expanded the scope of feasible applications, while recent U.S. tariff adjustments have underscored the importance of supply chain agility. Segmentation analysis reveals diverse value drivers across gene types, end-user categories, and workflow preferences. Regional insights highlight distinct investment climates and application priorities in the Americas, Europe Middle East & Africa, and Asia-Pacific, while leading companies continue to differentiate through specialized offerings and integrated platforms.Looking ahead, stakeholders who align their strategies with emerging best practices-modular service design, robust analytics, strategic partnerships, and regulatory engagement-will be best positioned to capitalize on the sector’s momentum. By balancing innovation with operational resilience, organizations can navigate evolving market dynamics and translate technological capabilities into sustained commercial success.
Market Segmentation & Coverage
This research report categorizes the Custom Synthetic Genes Services Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Advanced Synthetic Genes
- CRISPR Gene Editing
- Gene Assembly And Synthesis
- Basic Synthetic Genes
- Custom Cloning
- Site-Directed Mutagenesis
- Agricultural
- Genetically Modified Organisms
- Plant Biotechnology
- Pharmaceutical
- Drug Development
- Vaccine Development
- Research And Development
- Genomics
- Metabolomics
- Proteomics
- Academic And Research Institutes
- Private Research Organizations
- Public Universities
- Biotechnology And Pharmaceutical Companies
- Biotech Startups
- Established Pharmaceutical Companies
- Contract Research Organizations
- Large-Scale CROs
- Small-Scale CROs
- Cloning And Subcloning
- Fusion Cloning
- TA Cloning
- Gene Synthesis
- Gene Fragment Synthesis
- Oligonucleotide Synthesis
- Next-Generation Sequencing Technologies
- Targeted Sequencing
- Whole Genome Sequencing
- PCR-Based Technologies
- RT-PCR
- Traditional PCR
- Gene Fragments
- Circular
- Linear
- Plasmids
- Custom Plasmids
- Standard Plasmids
- Full Gene Construct Services
- Gene Design And Optimization
- Gene Replacement
- Standard Gene Synthesis Services
- Economical Gene Synthesis
- Express Gene Synthesis
This research report categorizes the Custom Synthetic Genes Services Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Custom Synthetic Genes Services Market to delves into recent significant developments and analyze trends in each of the following companies:
- Amgen Inc.
- Bioneer Corporation
- Eurofins Genomics Europe
- Genewiz, Inc. (a Brooks Automation company)
- Genomatica, Inc.
- Genscript Biotech Corporation
- Integrated DNA Technologies, Inc. (IDT)
- Sigma-Aldrich Co. LLC (part of Merck KGaA)
- Thermo Fisher Scientific, Inc.
- Twist Bioscience Corporation
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Custom Synthetic Genes Services Market, by Gene Type
8.1. Introduction
8.2. Advanced Synthetic Genes
8.2.1. CRISPR Gene Editing
8.2.2. Gene Assembly And Synthesis
8.3. Basic Synthetic Genes
8.3.1. Custom Cloning
8.3.2. Site-Directed Mutagenesis
9. Custom Synthetic Genes Services Market, by Application
9.1. Introduction
9.2. Agricultural
9.2.1. Genetically Modified Organisms
9.2.2. Plant Biotechnology
9.3. Pharmaceutical
9.3.1. Drug Development
9.3.2. Vaccine Development
9.4. Research And Development
9.4.1. Genomics
9.4.2. Metabolomics
9.4.3. Proteomics
10. Custom Synthetic Genes Services Market, by End-User
10.1. Introduction
10.2. Academic And Research Institutes
10.2.1. Private Research Organizations
10.2.2. Public Universities
10.3. Biotechnology And Pharmaceutical Companies
10.3.1. Biotech Startups
10.3.2. Established Pharmaceutical Companies
10.4. Contract Research Organizations
10.4.1. Large-Scale CROs
10.4.2. Small-Scale CROs
11. Custom Synthetic Genes Services Market, by Workflow
11.1. Introduction
11.2. Cloning And Subcloning
11.2.1. Fusion Cloning
11.2.2. TA Cloning
11.3. Gene Synthesis
11.3.1. Gene Fragment Synthesis
11.3.2. Oligonucleotide Synthesis
12. Custom Synthetic Genes Services Market, by Technology
12.1. Introduction
12.2. Next-Generation Sequencing Technologies
12.2.1. Targeted Sequencing
12.2.2. Whole Genome Sequencing
12.3. PCR-Based Technologies
12.3.1. RT-PCR
12.3.2. Traditional PCR
13. Custom Synthetic Genes Services Market, by Product Form
13.1. Introduction
13.2. Gene Fragments
13.2.1. Circular
13.2.2. Linear
13.3. Plasmids
13.3.1. Custom Plasmids
13.3.2. Standard Plasmids
14. Custom Synthetic Genes Services Market, by Service Type
14.1. Introduction
14.2. Full Gene Construct Services
14.2.1. Gene Design And Optimization
14.2.2. Gene Replacement
14.3. Standard Gene Synthesis Services
14.3.1. Economical Gene Synthesis
14.3.2. Express Gene Synthesis
15. Americas Custom Synthetic Genes Services Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Custom Synthetic Genes Services Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Custom Synthetic Genes Services Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Amgen Inc.
18.3.2. Bioneer Corporation
18.3.3. Eurofins Genomics Europe
18.3.4. Genewiz, Inc. (a Brooks Automation company)
18.3.5. Genomatica, Inc.
18.3.6. Genscript Biotech Corporation
18.3.7. Integrated DNA Technologies, Inc. (IDT)
18.3.8. Sigma-Aldrich Co. LLC (part of Merck KGaA)
18.3.9. Thermo Fisher Scientific, Inc.
18.3.10. Twist Bioscience Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET MULTI-CURRENCY
FIGURE 2. CUSTOM SYNTHETIC GENES SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. CUSTOM SYNTHETIC GENES SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CUSTOM SYNTHETIC GENES SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CUSTOM SYNTHETIC GENES SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE ASSEMBLY AND SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CUSTOM CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENETICALLY MODIFIED ORGANISMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLANT BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRIVATE RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PUBLIC UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ESTABLISHED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY LARGE-SCALE CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SMALL-SCALE CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FUSION CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TA CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENT SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RT-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CIRCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY LINEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CUSTOM PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE DESIGN AND OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ECONOMICAL GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY EXPRESS GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 148. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 149. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 150. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 151. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 153. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 154. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 155. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 157. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 159. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 160. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 161. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 162. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 164. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 165. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 166. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 167. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 168. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 169. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 170. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 171. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 172. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 174. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 183. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 184. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 187. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 188. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 189. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 190. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 265. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 266. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ADVANCED SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 267. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BASIC SYNTHETIC GENES, 2018-2030 (USD MILLION)
TABLE 268. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 270. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 271. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 272. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 274. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 275. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 276. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 277. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CLONING AND SUBCLONING, 2018-2030 (USD MILLION)
TABLE 278. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 279. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 281. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PCR-BASED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 282. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 283. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 284. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMIDS, 2018-2030 (USD MILLION)
TABLE 285. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 286. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY FULL GENE CONSTRUCT SERVICES, 2018-2030 (USD MILLION)
TABLE 287. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STANDARD GENE SYNTHESIS SERVICES, 2018-2030 (USD MILLION)
TABLE 28
Companies Mentioned
- Amgen Inc.
- Bioneer Corporation
- Eurofins Genomics Europe
- Genewiz, Inc. (a Brooks Automation company)
- Genomatica, Inc.
- Genscript Biotech Corporation
- Integrated DNA Technologies, Inc. (IDT)
- Sigma-Aldrich Co. LLC (part of Merck KGaA)
- Thermo Fisher Scientific, Inc.
- Twist Bioscience Corporation
Methodology
LOADING...
